Skip to Main Content

Paper Details

ADAMTSL2 protein and a soluble biomarker signature identify at-risk non-alcoholic steatohepatitis and fibrosis in adults with NAFLD.
J Hepatol
28
2022
A disintegrin and metalloproteinase with thrombospondin motifs like 2, ADAMTSL2, ADAMTSL2 protein, NAFL, NAFLD, NASH, Non-alcoholic fatty liver disease, fibrosis, liver disease, non-alcoholic fatty liver, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, scarring of the liver
Author NameAffiliation
Joseph LoureiroNovartis Institutes for BioMedical Research
Thomas J WangVanderbilt University School of Medicine
Thomas J WangVanderbilt University School of Medicine
Robert E GersztenDivision of Cardiovascular Medicine and Cardiovascular Institute
  • 1 - 4

Datasets

Release 1.2